U.S. News & World Report: Wegovy Helps Those With Both Diabetes, Heart Failure: Study
For people struggling with both diabetes and a common type of heart failure, the weight-loss drug Wegovy may do more for their health than help them shed pounds, new research suggests.
In the study, published Saturday in the New England Journal of Medicine, researchers reported that the drug helped people with type 2 diabetes who also had obesity-related "heart failure with preserved ejection-fraction," on several fronts.
This condition happens when the heart pumps normally, but the organ is too stiff to fill properly.
“I think the answer from the trial clearly suggests that, while weight loss is likely an important factor, it cannot explain everything,” study co-author Dr. Mikhail Kosiborod, a cardiologist and vice president of research at Saint Luke’s Health System in Kansas City, Mo., told CNN.
“I think that’s incredibly exciting because first of all, these patients are really difficult to treat and there are a lot more of them every day,” Kosiborod said. “And until recently, we had very little to offer them, so if we know it actually modifies the disease process, we have something really effective -- and by the way, really well-tolerated as well -- and that’s, of course, great news for patients and great news for doctors taking care of patients.”
Read the full U.S. News & World Report article: Wegovy Helps Those With Both Diabetes, Heart Failure: Study
